Organogenesis Hldgs (NASDAQ:ORGO) reported its Q1 earnings results on Wednesday, May 10, 2023 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
Organogenesis Hldgs beat estimated earnings by 50.0%, reporting an EPS of $-0.01 versus an estimate of $-0.02.
Revenue was up $9.53 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.02 which was followed by a 19.3% increase in the share price the next day.
Here’s a look at Organogenesis Hldgs’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | 0.05 | 0.06 | 0.08 | 0.05 |
| EPS Actual | 0.07 | 0.04 | 0.09 | 0.01 |
| Revenue Estimate | 122.40M | 120.85M | 120.90M | 95.93M |
| Revenue Actual | 115.52M | 116.86M | 121.40M | 98.12M |
To track all earnings releases for Organogenesis Hldgs visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
